Lapeyronie University Hospital, Intensive Care Department
Welcome,         Profile    Billing    Logout  
 6 Trials 
9 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
KLOUCHE, Kada
BICCS, NCT05681442: Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis

Recruiting
4
600
Europe
continuous pivotal βL-AB, CID group, intermittent pivotal βL-AB, IID control group, AG infusion most 1 dose, AMT group, AG infusion for 5 days, ACT Group
Assistance Publique - Hôpitaux de Paris
Sepsis
12/25
12/25
LevoHeartShock, NCT04020263 / 2019-001563-74: Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock

Recruiting
3
610
Europe
Levosimendan 2.5 MG/ML Injectable Solution, Placebo
Central Hospital, Nancy, France
Cardiogenic Shock
02/27
01/28
HyperBetashock, NCT04748796: Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility

Recruiting
3
360
Europe
echocardiography, Landiolol
Centre Hospitalier Universitaire, Amiens, CH Dieppe, CH Elbeuf, CH Le Havre, Centre Hospitalier de Beauvais, CH Compiègne, CH Laon, University Hospital, Caen, CH Cherbourg, University Hospital, Lille, CH Douai, CH Montreuil, Centre Hospitalier de Roubaix, Centre Hospitalier de Bethune, CH Lomme, Centre Hospitalier de Lens, Tourcoing Hospital, Centre Hospitalier VALENCIENNES, Centre Hospitalier Arras, Hospital Ambroise Paré Paris, University Hospital, Brest, Henri Mondor University Hospital, Hospital Avicenne, University Hospital, Montpellier, CH Calais, Hôpital Edouard Herriot, Centre Hospitalier Universitaire de Nīmes, Groupe Hospitalier Pitié-Salpêtrière
Septic Shock, Tachycardia, Mortality During Septic Shock, Beta-blocker
06/25
03/26
CarniSave, NCT02664753 / 2016-001977-34: L-carnitine as an Adjunct Treatment for Septic Shock Patients With Acute Kidney Injury

Recruiting
3
272
Europe
56 days of weight-adjusted L-Carnitine treatment, 10 days of intravenous placebo (isotonic saline)
Centre Hospitalier Universitaire de Nīmes
Severe Sepsis, Shock, Septic, Acute Kidney Injury
05/25
05/26
DE-RISK WF, NCT04696406: Multicenter, Multinational, Clinical Trial of the Performance of RESPINOR DXT to Identify Patients at Increased Risk of Weaning Failure

Completed
N/A
193
Europe
RESPINOR DXT
Respinor AS, The Research Council of Norway
Respiratory Failure
03/22
04/22
FAME, NCT05461521: Improving FAMily Members' Experience in the ICU

Completed
N/A
1346
Europe, RoW
Family members of patients admitted to the ICU, Health care professionals, Patients
Nantes University Hospital, Assistance Publique - Hôpitaux de Paris, Assistance Publique Hopitaux De Marseille
Stress Disorders, Post-Traumatic, Family Members
01/24
09/24
WeCAN, NCT06214390: Urinary Parameters to Predict Weaning of Renal Replacement Therapy in the Critically Ill

Not yet recruiting
N/A
600
Europe
Single strategy, Combined strategy
University Hospital, Montpellier
Acute Kidney Injury
09/25
12/25
RECO-OHCA, NCT06306625: REmote COnditioning in Out-of-Hospital Cardiac Arrest

Recruiting
N/A
220
Europe
Remote ischemic conditioning, No remote ischemic conditioning
Hospices Civils de Lyon
Out-Of-Hospital Cardiac Arrest
06/26
10/26
CORAIL, NCT05546606: CO2 Removal in Severe Acute exacerbatIons of Chronic Obstructive Lung Diseases

Active, not recruiting
N/A
17
Europe
ECCO2R
Assistance Publique - Hôpitaux de Paris, Ministry of Health, France, Xenios AG
COPD Acute Exacerbation
05/24
03/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
KLOUCHE, Kada
BICCS, NCT05681442: Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis

Recruiting
4
600
Europe
continuous pivotal βL-AB, CID group, intermittent pivotal βL-AB, IID control group, AG infusion most 1 dose, AMT group, AG infusion for 5 days, ACT Group
Assistance Publique - Hôpitaux de Paris
Sepsis
12/25
12/25
LevoHeartShock, NCT04020263 / 2019-001563-74: Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock

Recruiting
3
610
Europe
Levosimendan 2.5 MG/ML Injectable Solution, Placebo
Central Hospital, Nancy, France
Cardiogenic Shock
02/27
01/28
HyperBetashock, NCT04748796: Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility

Recruiting
3
360
Europe
echocardiography, Landiolol
Centre Hospitalier Universitaire, Amiens, CH Dieppe, CH Elbeuf, CH Le Havre, Centre Hospitalier de Beauvais, CH Compiègne, CH Laon, University Hospital, Caen, CH Cherbourg, University Hospital, Lille, CH Douai, CH Montreuil, Centre Hospitalier de Roubaix, Centre Hospitalier de Bethune, CH Lomme, Centre Hospitalier de Lens, Tourcoing Hospital, Centre Hospitalier VALENCIENNES, Centre Hospitalier Arras, Hospital Ambroise Paré Paris, University Hospital, Brest, Henri Mondor University Hospital, Hospital Avicenne, University Hospital, Montpellier, CH Calais, Hôpital Edouard Herriot, Centre Hospitalier Universitaire de Nīmes, Groupe Hospitalier Pitié-Salpêtrière
Septic Shock, Tachycardia, Mortality During Septic Shock, Beta-blocker
06/25
03/26
CarniSave, NCT02664753 / 2016-001977-34: L-carnitine as an Adjunct Treatment for Septic Shock Patients With Acute Kidney Injury

Recruiting
3
272
Europe
56 days of weight-adjusted L-Carnitine treatment, 10 days of intravenous placebo (isotonic saline)
Centre Hospitalier Universitaire de Nīmes
Severe Sepsis, Shock, Septic, Acute Kidney Injury
05/25
05/26
DE-RISK WF, NCT04696406: Multicenter, Multinational, Clinical Trial of the Performance of RESPINOR DXT to Identify Patients at Increased Risk of Weaning Failure

Completed
N/A
193
Europe
RESPINOR DXT
Respinor AS, The Research Council of Norway
Respiratory Failure
03/22
04/22
FAME, NCT05461521: Improving FAMily Members' Experience in the ICU

Completed
N/A
1346
Europe, RoW
Family members of patients admitted to the ICU, Health care professionals, Patients
Nantes University Hospital, Assistance Publique - Hôpitaux de Paris, Assistance Publique Hopitaux De Marseille
Stress Disorders, Post-Traumatic, Family Members
01/24
09/24
WeCAN, NCT06214390: Urinary Parameters to Predict Weaning of Renal Replacement Therapy in the Critically Ill

Not yet recruiting
N/A
600
Europe
Single strategy, Combined strategy
University Hospital, Montpellier
Acute Kidney Injury
09/25
12/25
RECO-OHCA, NCT06306625: REmote COnditioning in Out-of-Hospital Cardiac Arrest

Recruiting
N/A
220
Europe
Remote ischemic conditioning, No remote ischemic conditioning
Hospices Civils de Lyon
Out-Of-Hospital Cardiac Arrest
06/26
10/26
CORAIL, NCT05546606: CO2 Removal in Severe Acute exacerbatIons of Chronic Obstructive Lung Diseases

Active, not recruiting
N/A
17
Europe
ECCO2R
Assistance Publique - Hôpitaux de Paris, Ministry of Health, France, Xenios AG
COPD Acute Exacerbation
05/24
03/25

Download Options